CP1050

Formal title: CDCA MAR Discrepancy Values

Current Status

Submission
Assessment
CPC Consultation
Committee Decision
Withdrawn

Summary

BSCP06 states “the nominal tolerance value for acceptable MAR shall be not greater than ±0. 1%, and subject to review by the BSCCo. ” There appears to be an inconsistency in the industry documentation between the levels at which discrepancies should be investigated. Currently, in line with the Service Description, the CDCA is obliged to investigate any discrepancies greater than +/-0. 05%. Based on the CDCA’s experience of investigating MAR failures, it is our opinion that the tolerance that is currently used (0. 05%) is too tight, and results in wasted effort in investigating failures where obvious discrepancies cannot be identified, and where, in conjunction with the Registrant and/or MOA, these can be or are rarely resolved. This effort could be better focussed on resolving the significant issues.

Progression

This CP was withdrawn

My BSC

Click on the X next to any of the icons to replace them with a short-cut link to the page you are currently on or search for a specific page.

List of BSC Insights

Previous Circulars

Training videos and services

Market Entry

Charge Codes and Switch Regimes

Add New

×

Or